Literature DB >> 17162498

Determinants of the variability of aflatoxin-albumin adduct levels in Ghanaians.

B Dash1, E Afriyie-Gyawu, H J Huebner, W Porter, J S Wang, P E Jolly, T D Phillips.   

Abstract

Hepatocellular carcinoma (HCC) is a multifactorial disease with various host and environmental factors involved in its etiology. Of these, aflatoxin exposure has been established as an important risk factor in the development of HCC; the presence of aflatoxin-albumin (AA) adducts in the blood serves as a valuable biomarker of human exposure. In this study, the relationship between a variety of different HCC host factors and the incidence of AA adduct levels was examined in a Ghanaian population at high risk for HCC. These factors included age, gender, hepatitis virus B (HVB) and hepatitis C virus (HCV) status, and genetic polymorphisms in both microsomal epoxide hydrolase (mEH) and glutathione S-transferases (GSTs). Blood samples were analyzed for AA adducts and HBV and HCV status. GSTM1 and GSTT1 deletion polymorphisms and mEH exon 3 and exon 4 single-nucleotide polymorphisms (SNPs) were determined from urine samples. In univariate analysis, age, HBV and HVC status, and GSTT1 and mEH exon 3 genotypes were not associated with AA adduct levels. However, mean adduct levels were significantly higher in both females and individuals typed heterozygous for mEH exon 4 (vs. wild types). Stratification analysis also showed that gender along with mEH exon 4 genotype and HBV status had a significant effect on adduct levels. Both females typed HBsAg+ and males with mEH exon 4 heterozygote genotypes showed significantly higher adduct levels as compared to the HBsAg- and wild types, respectively. Understanding the relationships between these host factors and the variability in aflatoxin-adduct levels may help in identifying susceptible populations in developing countries and for targeting specific public health interventions for the prevention of aflatoxicoses in populations with HCC and chronic liver diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17162498     DOI: 10.1080/15287390600748880

Source DB:  PubMed          Journal:  J Toxicol Environ Health A        ISSN: 0098-4108


  5 in total

1.  Sulforaphane- and phenethyl isothiocyanate-induced inhibition of aflatoxin B1-mediated genotoxicity in human hepatocytes: role of GSTM1 genotype and CYP3A4 gene expression.

Authors:  Kerstin Gross-Steinmeyer; Patricia L Stapleton; Julia H Tracy; Theo K Bammler; Stephen C Strom; David L Eaton
Journal:  Toxicol Sci       Date:  2010-05-04       Impact factor: 4.849

Review 2.  Copy number variants in pharmacogenetic genes.

Authors:  Yijing He; Janelle M Hoskins; Howard L McLeod
Journal:  Trends Mol Med       Date:  2011-03-08       Impact factor: 11.951

Review 3.  Non‑infective occupational risk factors for hepatocellular carcinoma: A review (Review).

Authors:  Caterina Ledda; Carla Loreto; Christian Zammit; Andrea Marconi; Lucrezia Fago; Serena Matera; Valentina Costanzo; Giovanni Fuccio Sanzà; Stefano Palmucci; Margherita Ferrante; Chiara Costa; Concettina Fenga; Antonio Biondi; Cristoforo Pomara; Venerando Rapisarda
Journal:  Mol Med Rep       Date:  2016-12-14       Impact factor: 2.952

4.  Aflatoxin B1-induced hepatocellular carcinoma in developing countries: Geographical distribution, mechanism of action and prevention.

Authors:  Abdu Selim Hamid; Isaias Goitom Tesfamariam; Yucheng Zhang; Zhen Gui Zhang
Journal:  Oncol Lett       Date:  2013-01-31       Impact factor: 2.967

5.  Slaughterhouses Fungal Burden Assessment: A Contribution for the Pursuit of a Better Assessment Strategy.

Authors:  Carla Viegas; Tiago Faria; Mateus dos Santos; Elisabete Carolino; Raquel Sabino; Anita Quintal Gomes; Susana Viegas
Journal:  Int J Environ Res Public Health       Date:  2016-03-08       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.